October 24, 2025

Elinzanetant Approved for Menopausal Hot Flashes by FDA

Bayer’s dual neurokinin 1 and 3 receptor antagonist elinzanetant (Lynkuet) reduced the frequency and severity of menopausal vasomotor symptoms in phase 3 OASIS trials, providing a once daily, nonhormonal treatment option for moderate to severe hot flashes.

Conexiant

October 24, 2025

Endoscopist skill found to predict short-term post-colonoscopy cancer

In the short term, the quality of the endoscopist is a stronger driver of cancer risk than polyp characteristics.

Conexiant

October 24, 2025

Adoption is key challenge when introducing new dental technology, experts say

After new dental technology has gone through testing and approvals, developers still face the challenge of getting their product adopted.

ADA News

October 24, 2025

Zoonotic E coli Accounted for One-Fifth of UTI Cases

Genomic attribution estimates zoonotic share of community UTIs across Southern California.

Conexiant

October 24, 2025

Synbiotic Supplement Reduced Multiple Inflammatory Proteins

Butyrate rise corresponded with lower IL-6 during 6-week synbiotic supplementation.

Conexiant

October 24, 2025

A New Approach to Lowering Cardiovascular Risk?

Researchers evaluated obicetrapib’s effects on lipid levels and cardiovascular outcomes.

Conexiant

October 23, 2025

Waist Loss Only Part of Semaglutide’s Power

Semaglutide lowered cardiovascular events in patients with overweight or obesity without diabetes, independent of weight loss.

Conexiant

October 23, 2025

Can Sex Differences Really Explain Alzheimer’s Prevalence in Women?

Women account for most cases of Alzheimer’s globally, yet men show more age-related brain decline.

Conexiant

October 23, 2025

Chest Pain & Shock After a Tuna Sandwich: What’s Your Diagnosis?

A 30-year-old man with no prior medical history developed cardiogenic shock shortly after eating a tuna sandwich. He experienced central, burning chest pain, diaphoresis, and generalized pruritus. His pain worsened with breathing and did not respond to nitroglycerin.

Conexiant